Search research articles
Contact Us
Filters
Showing results (671-680 of 704) with videos related to
Page
of 71
Sort By:
BMC Psychiatry
|
July 6, 2021
Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study)
Lumbini Azim, Paul Hindmarch, Georgiana Browne, et al.
Health Technology Assessment (Winchester, England)
|
March 31, 2025
A group psychological intervention for postnatal depression in British mothers of South Asian origin - the ROSHNI-2 RCT
Nusrat Husain, Karina Lovell, Carolyn A Chew-Graham, et al.
Neuroscience and Biobehavioral Reviews
|
March 29, 2023
Consensus design of a calibration experiment for human fear conditioning
Dominik R Bach, Juliana Sporrer, Rany Abend, et al.
JMIR Neurotechnology
|
December 4, 2025
Clinical Perspectives on Using Remote Measurement Technology in Assessing Epilepsy, Multiple Sclerosis, and Depression: Delphi Study
Jacob A Andrews, Michael P Craven, Boliang Guo, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
December 7, 2018
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition
Diego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
Journal of Psychopharmacology (Oxford, England)
|
March 17, 2016
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
G M Goodwin, P M Haddad, I N Ferrier, et al.
Journal of Medicinal Chemistry
|
February 16, 2013
Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists
Panayiotis A Procopiou, John W Barrett, Nicholas P Barton, et al.
Lancet (London, England)
|
October 13, 2024
Efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women (ROSHNI-2): a multicentre, randomised controlled trial
Nusrat Husain, Farah Lunat, Karina Lovell, et al.
Health Technology Assessment (Winchester, England)
|
June 2, 2025
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial
Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 20, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)
R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Page
of 71
Search research articles
Search
Showing results (671-680 of 704) with videos related to
Sort By:
Page
of 71
BMC Psychiatry
|
July 6, 2021
Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study)
Lumbini Azim, Paul Hindmarch, Georgiana Browne, et al.
Health Technology Assessment (Winchester, England)
|
March 31, 2025
A group psychological intervention for postnatal depression in British mothers of South Asian origin - the ROSHNI-2 RCT
Nusrat Husain, Karina Lovell, Carolyn A Chew-Graham, et al.
Neuroscience and Biobehavioral Reviews
|
March 29, 2023
Consensus design of a calibration experiment for human fear conditioning
Dominik R Bach, Juliana Sporrer, Rany Abend, et al.
JMIR Neurotechnology
|
December 4, 2025
Clinical Perspectives on Using Remote Measurement Technology in Assessing Epilepsy, Multiple Sclerosis, and Depression: Delphi Study
Jacob A Andrews, Michael P Craven, Boliang Guo, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
December 7, 2018
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition
Diego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
Journal of Psychopharmacology (Oxford, England)
|
March 17, 2016
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
G M Goodwin, P M Haddad, I N Ferrier, et al.
Journal of Medicinal Chemistry
|
February 16, 2013
Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists
Panayiotis A Procopiou, John W Barrett, Nicholas P Barton, et al.
Lancet (London, England)
|
October 13, 2024
Efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women (ROSHNI-2): a multicentre, randomised controlled trial
Nusrat Husain, Farah Lunat, Karina Lovell, et al.
Health Technology Assessment (Winchester, England)
|
June 2, 2025
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial
Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 20, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)
R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Page
of 71